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Available online 22 April 2016Introduction: Telomeres may be considered markers of biological aging, shorter telomere length is associated
with some age-related diseases; in several studies short telomere length has also been associated to obesity in
adults and adolescents. However the relationship between telomere complex functions and obesity is still not
clear. Aim of the study was to assess telomere length (TL) in adults' obese subjects before and after weight loss
obtained by placement of bioenteric intragastric balloon (BIB) for 6 months.
Methods: We enrolled 42 obese subjects before and after BIB placement as weight loss intervention. Blood
samples were collected in order to obtain DNA from leukocyte to measure TL by quantitative PCR.
Results: Data were analyzed only in 37 subjects with complete data; all presented important body weight loss
(124.06 ± 26.7 vs 105.40 ± 23.14, p b 0.001) and more interesting they presented a signiﬁcant increase in TL
(3.58 ± 0.83 vs 5.61 ± 3.29, p b 0.001). Moreover we observed a signiﬁcant positive correlation between TL
elongation and weight loss (r = 0.44, p = 0.007) as well as an inverse correlation between TL at baseline and
TL elongation (r=−0.35, p= 0.03).The predictors of TL elongation were once again weight loss and short TL
at baseline (respectively p= 0.007 and p= 0.003).
Conclusions:Our study shows that weight loss is associated to telomere lengthening in a positive correlation: the
greater weight loss the greater telomere lengthening; moreover telomere lengthening is more signiﬁcant in
those subjects with shortest telomeres at baseline.






Telomeres consist of repetitive DNA sequences (TTAGGG) and are
located at the ends of linear chromosomes. They stabilize and protect
chromosomes from erosion and from being mistaken for double-
strand DNA breaks [1]. During each cell division, telomeres shorten
due to the “end-replication problem” that is the DNA polymerase's in-
ability to fully replicate the 3′ end of chromosomes. In order to limit
telomere attrition, germline and some somatic cells express telomerase,
a reverse transcriptase that maintains telomere length by synthesizing
new DNA sequences and adding them to the end of the chromosome
[2]. Telomerase is an enzymatic protein complex including the telome-
rase reverse transcriptase (TERT) and the telomerase RNA component
(TERC)used as a template to synthesize telomereDNA.When telomeres
are too short, they signal the arrest of cell proliferation.
Telomere length (TL) varies between individuals and depends on TL
at birth, reﬂecting a genetic inheritance and on the magnitude of telo-
mere erosion from birth onwards [3] which depends on cell replication
rate as well as on aging related exposure to agents that produce DNA
damage. Oxidative stress and inﬂammation are major contributors toMetabolic and Neural Sciences,
5, 41126 Modena, Italy.aging and aging related diseases and play an important role in telomere
attrition [4–6]. It is well known that obesity is a state of chronic inﬂam-
mation and great oxidative stress [7].
Available data on the relationship between obesity and TL in adults
have shown controversial results; some studies reported an inverse as-
sociation of TLwith obesity [8,9,11], but others did not [12,13] as also re-
cently reported in a review and meta-analysis [14]. Very recently two
studies showed a relationship between TL elongation with weight loss
as well as with a great adherence to Mediterranean diet [15,16]. To
the best of our knowledge there are no data on the relation between
weight loss obtained with BIB intervention and telomere length. The
Bioenteric Intragastric Balloon is an alternative gastric restrictive proce-
dure. It is a smooth, spherical, saline-ﬁlled, silicone elastomer with a ra-
diopaque ﬁlling valve. It is inserted endoscopically and left inﬂated
within the stomach. Insertion can be performed under conscious seda-
tion. It is intended to reduce weight by limiting food consumption The
BIB is not permanent and should be removed endoscopically after
6months to reduce the risk of long-term complications, such as balloon
perforation or migration and peptic ulceration [17]. The aim of this
study was to assess the relationship between TL and weight loss by
means of placement of Bioenteritc Intragastric Balloon (BIB) for
6months in severe obese adults.We hypothesized that a greaterweight
loss would lead to a greater elongation of TL as has been previously ob-
served in adult and adolescent studies [10,15].
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2.1. Study population
The study population included 42 severe obese adults undergoing
BIB placement for six months as weight loss intervention together
with a lifestyle education program supported by a multidisciplinary
team of nutritionists and psychologists. In the present study, we present
data before BIB placement and after removal at 6 months. Anthropo-
metric measurements and blood samples were collected for each pa-
tients before BIB placement and after its removal, they also underwent
an abdominal US in order to evaluate the presence of fatty liver and to
calculate the fatty liver indicator as previously described [18]. General
characteristics and anthropometric measures of the study population
at baseline and after 6 months, are shown in Table 1. Patients were
not diabetics. Written consent to participate to the study was obtained
from each participant. The study protocol was performed in accordance
with the ethical standards of the Declaration of Helsinki and the study
protocol was approved by the Institutional Ethics Committee.
2.2. Telomere length assay
Telomere length assay were performed according to Cawthon meth-
od as previously described [19,20]. Brieﬂy Telomere length was evaluat-
ed with a quantitative polymerase chain reaction (q-PCR)-based assay
using SYBR Green PCR mastermix (Applied Biosystems, Carlsbad, CA,
USA) in a real-time iCycler IQ system (Bio-Rad Laboratories, Hercules,
CA, US). Telomere DNA was ampliﬁed using 900 nM Telg primer (5′-
ACACTAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTAGTGT-3′) and 900 nM
Telc primer (5′-TGTTAGGTATCCCTATCCCTATCCCTATCCCTATCCCTAA
CA-3′); genomic DNA was challenged with 900 nM albu primer (5′-
CGGCGGCGGGCGGCGCGGGCTGGGCGGAAA GCTGCACAGAATCCTTG-3′)
and 900 nM albd primer (5′-GCCCGGCCCGCCGCGCCCGTCC CGCCGGAA
AAGCATGGTCGCCTGTT-3′) to amplify the single copy albumin gene.
Telomere length and albumin copy number were evaluated in a single
qPCR reaction and samples (20 ng DNA) were measured in ﬁve repli-
cates. The thermal cycling proﬁle was: Stage 1: 15 min at 95 °C; Stage
2: 2 cycles of 15 s at 94 °C, 15 s at 49 °C; and Stage 3: 32 cycles of 15 s
at 94 °C, 10 s at 62 °C, 15 s at 74 °C with signal acquisition, 10 s at
84 °C, 15 s at 88 °C with signal acquisition. Following ampliﬁcation, dis-
sociation curves were analyzed to conﬁrm the speciﬁcity of the reaction.Table 1
General characteristics of study population at baseline and after weight loss with BIB
treatment.
Data are expresses as mean ± SD. Abbreviations. SBP: Systolic blood pressure, DBP:
diastolic blood pressure, CRP: C reactive protein, TL: telomere length, FLI: fatty liver index,
AST: aspartate transaminase, ALT: alanine transaminase ,GGT: gamma glutamyl
transferase, ALP: alkaline phosphatase, BIL: bilirubin.
n= 37 PRE BIB POST BIB P
Age 40,61 ± 10.12 –
Sex (M/F) 14/23 –
Weight (kg) 124.06 ± 26.7 105.40 ± 23.14 0.000
BMI (m2/cm) 43.9 ± 8.01 39.97 ± 7.72 0.000
Glycaemia 96.92 ± 20 91.00 ± 10.48 0.032
TOT-cholesterol (mg/dl) 190.63 ± 31.07 180.82 ± 32.98 0.086
HDL-cholesterol (mg/dl) 42.39 ± 8.09 43.23 ± 11.62 0.013
LDL-cholesterol (mg/dl) 132,62 ± 28,9 123,59 ± 26.13 0.07
Triglycerides (mg/dl) 138.54 ± 47.42 107.97 ± 39.53 0.000
SBP (mm Hg) 142.32 ± 17.68 127.00 ± 15.65 0.002
DBP (mm Hg) 82.85 ± 11.41 78.00 ± 11.91 0.153
CRP (mg/l) 2.87 ± 12.8 1.05 ± 1.17 0.036
TL 3.58 ± 0.83 5.61 ± 3.29 0.000
FLI 4.53 ± 2.37 2.65 ± 2.25 0.000
AST (U/l) 26.37 ± 12.04 20.80 ± 5.47 0.002
ALT(U/l) 34.50 ± 21.16 23.64 ± 13.78 0.000
GGT(U/l) 28.80 ± 16.66 20.00 ± 13.32 0.000
ALP (mU/ml) 68.11 ± 15.5 64.11 ± 22.43 0.208
BIL (mg/dl) 0.98 ± 0.53 0.94 ± 0.50 0.608Dissociation curves and Ct valueswere generated by the iQTM5 Software
(Bio-Rad Laboratories). The relative telomere/single copy gene ratio (T/
S-ratio value) was calculated as described by as an expression of the
relative average LTL in genomic DNA samples.
3. Statistical analysis
As a preliminary analysis, one-sample Kolmogorov-Smirnov test
was performed, in order to detect deviations from the normal distribu-
tion in the studied variables. The test did not allow in rejecting the null
hypothesis for any of the variables studied, and therefore a normal dis-
tribution was assumed for the subsequent analyses.
We used the paired t-test for comparing the parameters at baseline
and after 6 months, expressed as mean ± SD. With the present patient
population, power analysis showed that a predicted observation of a
50% variation in TL from an initial length of 3.5 and a SD of 2 [15,19]
could be associated with a type-II error (risk of a false negative result)
of 0.01, when keeping a signiﬁcance level of 0.05.
We also calculated the Pearson correlation coefﬁcient (r) between
all the variables and performed a multiple stepwise regression analysis
with the variation in TL as dependent variable and the other continuous
variables (weight change, pretreatment TL, weight, BMI, age, systolic
blood pressure, cholesterol, triglyceride, fatty liver index) as the inde-
pendent ones.
In order to deﬁne gender-related differences in the presentation of the
data, correlation analysis was repeated separately for males and females.
Furthermore, analysis of covariance was performed, keeping TL variation
as the dependent variable,with sex as theﬁxed factor and the others (age,
baseline TL, baseline weight, weight variation) as covariates.
Statistical analyses were performed using SPSS 17 software on a PC
workstation. The signiﬁcance level for all the analyses was set at
P ≤ 0.05. Power analysis was performed with G*Power 3.1 software.
4. Results
The resultswere analyzed only in a series of 37 subjects having com-
plete data available. Table 1 summarizes the general features of the 37
study subjects at baseline and after 6 months at BIB removal.
Baseline TL was not correlated with age nor with most of the meta-
bolic variables investigated (BMI, total cholesterol, HDL-Cholesterol)
(p N 0.1, data not shown). A signiﬁcant correlation was detected be-
tween TL and serum triglycerides (r=−0.36, P= 0.028).
As shown in Table 1, all subjects did signiﬁcantly lose body weight
(124.06 ± 26.7 vs 105.40 ± 23.14, P b 0.001) after BIB placement,
which was accompanied by a signiﬁcant improvement in BMI
(43.9 ± 8.01 vs 39.97 ± 7.72, P b 0.001), glycaemia (96.92 ± 20
vs91.00±10.48, p=0.03), CRP (2.87±12.8 vs 1.05±1.17, p=0.036).
We observed signiﬁcant reductions in HDL-cholesterol (42.39 ±
8.09 vs 43.23 ± 11.62, P= 0.013) and triglycerides(138.54 ± 47.42 vs
107.97 ± 39.53, P b 0.001), but not in total-cholesterol (190.63 ±
31.07 vs 180.82 ± 32.98, P = 0.086), that was within the normal
range already at baseline, and in LDL-cholesterol (132.62 ± 28.9 vs
123.59 ± 26.13, P = 0.07). Systolic blood pressure was also reduced
afterweight loss (142.32±17.68 vs 127.00± 15.65, P=0.002)where-
as diastolic blood pressure did not change (82.85 ± 11.41 vs 78.00 ±
11.91, P= 0.153).
TL was markedly increased after weight loss (3.58 ± 0.83 vs 5.61 ±
3.29, P b 0.001).
Fatty Liver Index (FLI), that reﬂects severity of fatty liver, was signif-
icantly reduced after weight loss (4.53± 2.37 vs 2.65± 2.25, P b 0.001)
as well as AST and ALT (respectively, 26.37 ± 12.04 vs 20.80 ± 5.47,
P = 0.002 and 34.50 ± 21.16 vs 23.64 ± 13.78, P b 0.001) and ALP,
GGT and bilirubin.
As shown in Fig. 1 we observed a positive signiﬁcant correlation be-
tween TL elongation and weight loss suggesting that a greater weight
Fig. 1. Telomere length change after weight loss as a function of weight loss change. The
scatter plot shows the entire sample (n= 37) with each dot representing one individual.
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0.007).
Moreover as shown in Fig. 2, the telomere elongation was inversely
correlatedwith TL at baseline suggesting that those subjectswith longer
TL at baseline had a lower elongation despite the weight loss and that
the elongating rate was more important in those subjects with short
telomere at baseline (r=−0.35, P= 0.03).
When analyzing the data formen andwomen separatelywe observed
the same signiﬁcant results for women in the correlation between TL
elongation and weight loss (r= 0.44, p= 0.003) and in the inverse cor-
relation between telomere elongation and TL at baseline (r =−0.536,
p=0.008). No signiﬁcant correlation for menwas observed in the corre-
lation between TL elongation andweight loss(r=0429,P=0.126) nor in
the inverse correlation between telomere elongation and TL at baseline
(r =−0.010, p = 0.974). Furthermore, analysis of covariance with sex
as the ﬁxed factor and the other variables as covariates showed a signiﬁ-
cant difference between genders (F = 3.29, P= 0.017).
At a stepwise regression analysis with TL elongation as dependent
variable and all the others features as independent variables we ob-
served that weight loss change and short TL at baseline were the only
predictors of TL elongation (model 1, with baseline TL as a predictor:
F = 6.84, P = 0.014; model 2, with baseline TL and weight variation
as predictors: F = 6.85, P= 0.004).5. Discussion
In this study conducted on 37 obese subjects, a signiﬁcant increase in
TL after 6 months of weight loss intervention was observed. Our resultsFig. 2. Telomere length change after weight loss as a function of telomere length at
baseline. The scatter plot shows the entire sample (n = 37) with each dot representing
one individual.are consistent with previously published studies on the beneﬁts of a
healthy lifestyle such as Mediterranean diet and weight loss on telo-
mere length [15,16], therefore in promoting health and longevity.
Interestingly, we observed that TL elongation correlated positively
with the body weight loss indicating that the lengthening rate was most
pronounced in individuals with a greater weight loss. We showed that
weight loss interventions contribute not only on prevention of telomere
shortening but also and more important on telomere elongation. The
same signiﬁcant results were observed also when adjusting for age, sex
and BMI, indicating these important modulating factors play no role in
telomere lengthening in the presence of important weight loss.
When analyzing the data separately for men and women, results
were conﬁrmed signiﬁcant for women but not for men. This could be
partly due to the smaller number of men analyzed, compared with
women (14 vs 23). At any rate, a gender-speciﬁc effect of the changes
observed cannot be ruled out, as suggested by analysis of variance;
this is also consistent with evidence in the literature showing longer
telomeres in females, possibly due to hormonal inﬂuences [21,22].
These data are also in concordance with other studies on adults and
adolescents on TL andweight loss obtained with life style modiﬁcations
[15,16].
Garcia-Calzon et al. [15] in the “EVASYON STUDY” showed that
weight loss intervention was accompanied by a signiﬁcant increase of
TL in overweight/obese adolescents and that TL at baseline was a better
predictor of weight loss.
Moreover in a very recent study Crous-Bou et al. [16] in a population
based cohort study showed that a greater adherence to Mediterranean
diet was associated with longer telomeres. The mechanism responsible
for telomere lengthening may be the reduction in oxidative stress and
inﬂammation which associates to weight loss; it is well established
that oxidative stress and chronic inﬂammation are typical features of
obesity and have been reported to accelerate telomere attrition [5–7].
Telomere DNA is very sensitive to damage by oxidation suggesting
that oxidative stress plays an important role on telomere loss and that
replicative senescence may be considered a stress response blocking
the growth of cells that might be at high risk of mutation [23]. Surpris-
ingly our data are not in concordance with the data presented in a re-
cent study [24] conducted on severe obese subjects undergoing
bariatric surgery. The Authors showed data on TL in obese patients
prior to and 3, 6, 9 and 12 months after bariatric surgery, showing that
TL was signiﬁcantly shorter than baseline at 3, 6, 9 and 12 months
after bariatric surgery. Their results conﬁrm that obese subjects have
shorter telomeres compared to non-obese subjects. But more interest-
ingly that TL shows an additional attrition during the immediate post-
operative period, probably due to a catabolic state.
In fact in a recent study by Laimer et al. [25], in a 10 years a prospec-
tive study, on obese subjects undergoing bariatric surgery, it was ob-
served an signiﬁcant increase in TL after bariatric surgery in the long
term, presumably due to the amelioration of themetabolic traits and in-
ﬂammatory and catabolic state of the immediate post operative period.
In our study, is even more interesting the ﬁnding that the change in
TL or TL elongationwas inversely correlatedwith TL at baseline suggest-
ing the lengthening rate was most pronounced in individuals with
shorter telomeres at baseline. Shortest TL at baseline presented the
greatest increase after weight loss, also this ﬁnding is in concordance
with other studies in the literature [26–28]. Nordfjall K et al. [26], taking
two blood samples from the same subjects, after a 10 years interval, ob-
served that telomere attrition ratewas signiﬁcantly inversely correlated
with initial TL indicating that the attrition rate was most pronounced in
individuals with long telomeres at baseline. Moreover Aviv et al. [27] in
the “Bogalusa study” observed that age-dependent TL shortening was
proportional to TL at baseline, underlining the complexity of telomere
dynamics in vivo and suggesting that other factors in addition to the
“end-replication problem” may inﬂuence the telomere shortening
in vivo. In the Finnish Diabetes Prevention Study [28] the main ﬁnding
was that TL increased in about two thirds of the individuals after life
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shortest TL at the ﬁrst measurement. It is reasonable to think that the
TL maintenance mechanisms are mainly focusing on protecting the
shortest telomeres [29–31] and challenging the hypothesis that individ-
ual TL can predict possible life span or later tumor development.
The data on fatty liver improvement with weight reduction are not
only in accordance with the literature but recently Lee et al. showed
that weight loss obtained with BIB placement for 6 months provided a
great improvement of nonalcoholic fatty liver disease on liver histology
[32].
To the best of our knowledge there are no data on weight loss ob-
tained with BIB placement and telomere length and this, in our opinion,
represents an important point of interest of the present ﬁndings.
Some limitations of the present study need to be considered. First of
all the design of our study, both for logistic and ethical considerations,
did not include a control group; nonetheless, analysis of the literature
and of the data of our historical controls [15,16,19] seem to be consis-
tent with the present results. Another potential limitation is represent-
ed by the relatively limited sample size, due to the peculiar design of the
study that is precluded to obtain a larger patient population. Post-hoc
power analysis, though, conﬁrmed that such population size should
have been adequate to detect a statistical signiﬁcance of the predicted
variation in TL, and this was conﬁrmed by the experimental data.
Finally, in this work we considered a short intervention period, and
therefore some individuals may be considered erroneously TL gainers
as described in the literature [33]. Our results are consistent with the
view that, in morbid obese adult subjects, weight loss intervention
with bioenteric intragastric balloon did achieve not only weight loss,
but an increase in telomere length, indicating that obesity may hasten
the aging process and supporting the evidence of a healthy life style
on longevity and health. Further larger longitudinal studies are needed
to conﬁrm these results and to better understand the complicated asso-
ciation between telomere complex function and obesity as well as obe-
sity related diseases.
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